Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

Inclusion Criteria: * children 0-6 years of age. * clinical diagnosis of blepharoconjunctivitis * Parent/guardian must understand, be willing and able to comply with all treatment and follow-up procedures. * Parent/guardian must understand, be willing and able to provide informed consent and Health Insurance Portability Accountability Act (HIPAA) authorization. Exclusion Criteria: * Known hypersensitivity to corticosteroids, aminoglycosides, or any component of the study medication. * Subjects who have a history of ocular surgery, including laser procedures, within the past 6 months. * Subjects who are monocular. * Subjects who have a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study. * Subjects who have participated in an ophthalmic drug or device research study within 30 days prior to entry in this study.